When ordering liver function tests, in which clinical situations should I use alanine aminotransferase (ALT) versus alkaline phosphatase (ALP)?

When to Use ALT vs ALP in Liver Function Testing

Use ALT to detect hepatocellular injury (damage to liver cells themselves) and ALP to detect cholestatic disease (problems with bile flow or biliary obstruction). 1

Understanding the Pattern-Based Approach

The key to interpreting liver function tests lies in recognizing whether you're dealing with a hepatocellular pattern (liver cell damage) versus a cholestatic pattern (bile flow obstruction):

Use ALT When Suspecting Hepatocellular Injury

ALT is the most specific marker for liver cell damage and should be your primary test when evaluating for hepatocellular disease. 1, 2

• ALT elevations are highly specific for liver injury because ALT has low concentrations in skeletal muscle and kidney, unlike AST which can be elevated from heart, muscle, kidney, brain, and red blood cell disorders 1

• Order ALT when evaluating for:

  • Nonalcoholic fatty liver disease (NAFLD) - the most common cause of mild ALT elevation 1
  • Alcohol-induced liver disease 1
  • Viral hepatitis (acute or chronic) 1
  • Drug-induced liver injury 1
  • Autoimmune hepatitis 1
  • Hemochromatosis, Wilson disease, alpha-1 antitrypsin deficiency 1
  • Ischemic hepatitis or Budd-Chiari syndrome 1

• Hepatocellular predominance is defined as aminotransferases (ALT/AST) elevated much higher than ALP 1

Use ALP When Suspecting Cholestatic Disease

ALP is the primary marker for cholestasis and should be ordered when biliary obstruction or bile flow impairment is suspected. 1

• ALP is produced in the canalicular membrane of hepatocytes and biliary epithelium, making it sensitive for detecting cholestatic processes 1

• Order ALP when evaluating for:

  • Extrahepatic biliary obstruction (choledocholithiasis, malignant strictures, biliary strictures) 1
  • Primary biliary cholangitis 1
  • Primary sclerosing cholangitis 1
  • Drug-induced cholestasis 1
  • Infiltrative liver diseases (sarcoidosis, amyloidosis, hepatic metastases) 1

• Cholestatic predominance is defined as ALP elevated disproportionately compared to ALT/AST 1, 2

• If ALP is elevated in isolation without other liver enzyme abnormalities, cholestatic disease is the suspected etiology 1

Practical Initial Testing Strategy

The optimal initial liver function panel should include bilirubin, albumin, ALT, ALP, and GGT together to capture both hepatocellular and cholestatic patterns. 1

Critical Caveats:

• ALP can be elevated from non-hepatic sources (bone disease like Paget's disease, bony metastases, fractures; also physiologically elevated in children and pregnancy) 1

  • Add GGT to confirm hepatic origin of elevated ALP, as GGT is found in liver but not bone 1

• Normal ALT does not exclude cirrhosis - both AST and ALT can be normal even in advanced liver disease 1

• The conventional teaching that ALP rises more than AST in obstructive jaundice applies mainly to strictures, but in bile duct stone disease, AST may equal or even exceed ALP elevation, especially during acute pain episodes 3

Severity Classification for ALT Elevations:

• Mild: <5 times upper reference limit 1
• Moderate: 5-10 times upper reference limit 1
• Severe: >10 times upper reference limit 1

Updated Reference Ranges:

Use gender-specific ALT reference ranges for improved sensitivity: 29-33 IU/L for males and 19-25 IU/L for females (though recent data suggests even lower cutoffs of 34 IU/L for males and 22 IU/L for females may be more appropriate). 1, 4